ALGS - Aligos Therapeutics GAAP EPS of -$0.43 beats by $0.06 revenue of $2.59M August, 03 2023 05:59 PM Aligos Therapeutics Inc. 2023-08-03 17:59:34 ET Aligos Therapeutics press release ( NASDAQ: ALGS ): Q2 GAAP EPS of -$0.43 beats by $0.06 . Revenue of $2.59M (-29.8% Y/Y). For further details see: Aligos Therapeutics GAAP EPS of -$0.43 beats by $0.06, revenue of $2.59M